Bioequivalence Study Between YHP1906 Tab. 5 mg and YHR1902 Tab. 5 mg

NCT04316065 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteers

Interventions

DRUG: YHP1906
DRUG: YHR1902

Sponsor

Yuhan Corporation

Collaborators

[object Object]